Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

admin.veranex : Mar 24, 2025 10:22:49 PM

Commercial Strategy & Market Access

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey. Hypothetical patient profiles created using clinical parameters demonstrated the clinical utility of a novel kidney diagnostic used to risk-stratify patients based on the risk of kidney function decline.

Read the Article

Study by Veranex and Proteomics International Demonstrates Clinical Utility of Prognostic Test for Type 2 Diabetes Patients

admin.veranex : Mar 24, 2025 10:23:07 PM

By conducting a clinical utility study for Proteomics International’s PromarkerD (a blood-based test that predicts the risk of kidney...

Commercial Strategy & Market Access
Read More

Leveraging Medtech Innovation in Clinical Trials

admin.veranex : Mar 24, 2025 10:23:11 PM

Rebecca Ford, Director of Program Management, discusses how to Leverage medical technology and innovation in clinical trials to drive medication...

Read More

Recent Study Co-authored by Veranex Staff Highlights Cost-effectiveness of Home Non-invasive Ventilation in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom

admin.veranex : Mar 24, 2025 10:23:08 PM

By developing a cost-effectiveness model and associated manuscript for home non-invasive ventilation in patients with persistent hypercapnia after...

Commercial Strategy & Market Access Articles
Read More